Harrow Health, Inc.'s non-ophthalmic compounding business Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Location

Primary Industry

Pharmaceuticals

About

Based in the US, Harrow Health, Inc.'s non-ophthalmic compounding business is the non-eye care pharmaceutical business unit of Harrow Health. In October 2022, the business segment was acquired by Revelation Pharma Corporation LLC, a portfolio company of Osceola Capital Management. Harrow Health, Inc.'s non-ophthalmic compounding business includes non-eye care pharmaceutical business, formulations, customer accounts, and other related assets.

Current Investors

Revelation Pharma Corporation LLC

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Deals

Deals Type
Add-on

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	Harrow Health, Inc.'s non-ophthalmic compounding business	05 Oct 2022

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.